ExactAb™,低内毒素,已验证,无动物源,无叠氮钠,无载体,重组 级 提供 ≥95%(SDS-PAGE&SEC-HPLC) 纯度，适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 2 篇同行评审文献引用。
Cetuximab (anti-EGFR) 是一种人源 IgG1 单克隆抗体，能够抑制 EGFR, Cetuximab (anti-EGFR) 具有高效的抗肿瘤作用。
Cetuximab (anti-EGFR) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR). Cetuximab (anti-EGFR) has potent antitumor activity.
Cetuximab (anti-EGFR) (C411992) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling EGFR (red) with Cetuximab (anti-EGFR) (C411992). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Cetuximab (anti-EGFR) (C411992) - SEC
The purity of Cetuximab (anti-EGFR) (C411992) is more than 95% verified by HPLC.
Cetuximab (anti-EGFR) (C411992) - ELISA
Immobilized Human EGFR-Fc at 2 μg/mL can bind Cetuximab (anti-EGFR) (C411992) with the EC₅₀ of 10.67 ng/mL.
Cetuximab (anti-EGFR) (C411992) - ELISA
Immobilized Recombinant Human EGFR protein (rp176273) at 1.0 μg/mL can bind Cetuximab (anti-EGFR) (C411992) with the EC50 of 17.44 ng/mL.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
 ZJ24F0911235 |
分析证书 | C411992 |
| ZJ24F0911238 |
分析证书 | C411992 |
| ZJ23F0901157 |
分析证书 | C411992 |
| ZJ25F0521990 |
分析证书 | C411992 |
| ZJ23F0901156 |
分析证书 | C411992 |
| 1. Liyin Wang, Milad Ashrafizadeh, Gautam Sethi, Xinjia Zhou. (2025) pH-responsive biomimetic zeolitic imidazolate framework-based nanoparticles for co-delivery of cetuximab and siRNA in synergistic therapy of laryngeal squamous cell carcinoma. Journal of Pharmaceutical Analysis, [PMID:40735032] [10.1016/j.jpha.2025.101203] |
| 2. Li Jinbo, Yu Jiang, Song Jia, Zhang Yingxi, Li Ning, Wang Zhaomeng, Qin Meng, Zhao Mingming, Zhang Baoyue, Huang Ruiping, Zhou Shuang, Liu Yubo, He Zhonggui, Liu Hongzhuo, Dan Liu, Wang Yongjun. (2025) Galloylated liposomes enable targeted drug delivery by overcoming protein corona shielding. Nature Communications, 16 (1): (1-15). [PMID:40854890] [10.1038/s41467-025-63198-4] |
我们的级别选择指南涵盖了目录中所有的变体的纯度、稳定剂状态和应用适用性。
查看 Animal Free 级别指南 → 查看 Carrier Free 级别指南 → 查看 Recombinant 级别指南 → 查看 Validated 级别指南 → 查看 ExactAb™ 级别指南 → 查看 Low Endotoxin 级别指南 → 查看 Azide Free 级别指南 →
危险品化学品经营许可证（带存储）